Editorial
Published on 18 Apr 2023
Editorial: Immune checkpoint inhibitors in renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1203463
- 1,159 views
- 1 citation
Type at least 3 characters
1,560 articles
Articles
Original Research
Published on 14 Apr 2023
Benefits of lymphadenectomy for upper tract urothelial carcinoma only located in the lower ureter: a bicentre retrospective cohort study
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1115830
- 1,584 views
- 2 citations
Original Research
Published on 14 Apr 2023
Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1170893
- 5,231 views
- 2 citations
Original Research
Published on 14 Apr 2023
Emerging trends of BCG immunotherapy for bladder cancer in last decade: a bibliometric and visualization analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1092969
- 2,752 views
Editorial
Published on 13 Apr 2023
Editorial: Reviews in genitourinary oncology
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1196769
- 978 views
Original Research
Published on 12 Apr 2023
A comparison of machine learning models for predicting urinary incontinence in men with localized prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1168219
- 2,737 views
- 3 citations
Original Research
Published on 11 Apr 2023
Prognostic role of plasma vitamin D and its association with disease characteristics in germ cell tumours
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1149432
- 1,748 views
- 1 citation
Systematic Review
Published on 05 Apr 2023
Erectile function, urinary continence and oncologic outcomes of neurovascular bundle sparing robot-assisted radical prostatectomy for high-risk prostate cancer: A systematic review and meta-analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1161544
- 1,989 views
- 4 citations
Original Research
Published on 05 Apr 2023
Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1161089
- 2,880 views
- 6 citations
Editorial
Published on 04 Apr 2023
Editorial: Magnetic resonance imaging applications for the diagnosis of prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1191543
- 809 views
Original Research
Published on 03 Apr 2023
Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1108937
- 2,715 views
- 2 citations
Original Research
Published on 03 Apr 2023
Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1115718
- 2,493 views
- 6 citations
Original Research
Published on 30 Mar 2023
Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1131473
- 3,085 views
- 5 citations
Case Report
Published on 30 Mar 2023
Malignant glomus tumor of prostate: A case report
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1121307
- 1,140 views
- 3 citations
Case Report
Published on 30 Mar 2023
Primary squamous cell carcinoma of renal parenchyma: A case report and literature review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1037156
- 3,448 views
- 1 citation
Original Research
Published on 29 Mar 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1113246
- 1,545 views
- 3 citations